Dillon & Associates Inc. Has $13.83 Million Holdings in Danaher Co. (NYSE:DHR)

Dillon & Associates Inc. increased its position in shares of Danaher Co. (NYSE:DHR) by 3.2% during the third quarter, Holdings Channel.com reports. The institutional investor owned 49,740 shares of the conglomerate’s stock after purchasing an additional 1,564 shares during the period. Danaher accounts for 1.9% of Dillon & Associates Inc.’s investment portfolio, making the stock its 16th largest holding. Dillon & Associates Inc.’s holdings in Danaher were worth $13,828,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. CarsonAllaria Wealth Management Ltd. bought a new stake in Danaher in the second quarter valued at approximately $25,000. nVerses Capital LLC acquired a new stake in Danaher during the 2nd quarter valued at $25,000. MFA Wealth Advisors LLC acquired a new position in shares of Danaher in the second quarter valued at $51,000. Financial Connections Group Inc. bought a new position in shares of Danaher in the second quarter valued at about $51,000. Finally, Western Pacific Wealth Management LP bought a new stake in shares of Danaher during the 1st quarter worth about $55,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity

In other news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 10.90% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of several research analyst reports. UBS Group lowered their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Royal Bank of Canada dropped their price target on Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Leerink Partners increased their price objective on Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Stephens reissued an “overweight” rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Finally, Robert W. Baird lowered their price target on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Price Performance

Shares of DHR opened at $239.59 on Wednesday. The business has a 50-day moving average of $264.37 and a 200-day moving average of $260.82. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The company has a market capitalization of $173.05 billion, a price-to-earnings ratio of 45.72, a price-to-earnings-growth ratio of 4.47 and a beta of 0.85. Danaher Co. has a 1 year low of $193.75 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same period in the prior year, the company posted $2.02 earnings per share. Danaher’s revenue for the quarter was up 3.1% compared to the same quarter last year. As a group, equities research analysts anticipate that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.